🔎 Trials Near Me

Akèy › Neyofibòm Plexifòm › Pennsylvania

Etid klinik pou Neyofibòm Plexifòm nan Pennsylvania

4 etid pou Neyofibòm Plexifòm ap chèche patisipan nan sit nan Pennsylvania.

Vil nan Pennsylvania

Tèks ofisyèl etid la (Anglè)

Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)

  • Children's Hospital of Philadelphia, Philadelphia
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 5 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT02544022

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

  • Children's Hospital of Philadelphia, Philadelphia
Ap rekriteFaz 1
Laj 16 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06502171

A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1

  • Children's Hospital of Philadelphia, Philadelphia
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT06541847

Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1

  • Children's Hospital of Philadelphia, Philadelphia
Ap rekriteFaz 2
Laj 1 a 8 · Tout sèks · Mizajou May 29, 2026 · NCT06188741

Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.